Titan Pharmaceuticals
TTNP
#10415
Rank
A$9.17 M
Marketcap
A$6.90
Share price
-3.76%
Change (1 day)
33.18%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$7.05 Million, an increase over its 2023 earnings that were of -A$8.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-38.64%
2024 -A$7.05 Million-15.5%
2023 -A$8.34 Million-45.43%
2022 -A$15.28 Million16.29%
2021 -A$13.14 Million-907.36%
2020 A$1.62 M-106.6%
2019 -A$24.64 Million82.4%
2018 -A$13.51 Million-36.93%
2017 -A$21.42 Million-378.62%
2016 A$7.68 M-145.53%
2015 -A$16.89 Million369.37%
2014 -A$3.6 Million-125.9%
2013 A$13.88 M-177.74%
2012 -A$17.87 Million13.59%
2011 -A$15.73 Million74.37%
2010 -A$9.02 Million3.61%
2009 -A$8.71 Million
2007 -A$27.6 Million12.08%
2006 -A$24.62 Million-28.65%
2005 -A$34.51 Million-10.03%
2004 -A$38.36 Million-6.08%
2003 -A$40.84 Million-14.76%
2002 -A$47.91 Million32.52%
2001 -A$36.16 Million27.55%
2000 -A$28.35 Million62.5%
1999 -A$17.45 Million4.04%
1998 -A$16.77 Million49.33%
1997 -A$11.23 Million-27.88%
1996 -A$15.57 Million13.04%
1995 -A$13.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-A$0.19 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$17.97 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.39 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.49 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.57 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
A$39.13 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA